Amylyx Pharmaceuticals priced Relyvrio “way too high,” said one patient. “They could cut the price in half and still make a hefty profit.” Read More
Amylyx Pharmaceuticals priced Relyvrio “way too high,” said one patient. “They could cut the price in half and still make a hefty profit.” Read More
